Pennant Investors »

Novavax shares owned by Pennant Investors

Quarter-by-quarter ownership of Novavax (NVAX) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Novavax

Tip: Access up to 7 years of quarterly data

All positions including Novavax held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novavax by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $288k 60k 4.78

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Novavax

Vanguard Group
BlackRock
Himanshu H. Shah
Susquehanna International
Citigroup
Geode Capital Management
Bank of America Corporation
Morgan Stanley
Rafferty Asset Management
Citadel Advisors
TSP Capital Management Group
Bank Of Montreal
Graham Capital Management
Farallon Capital Management
Northern Trust

View all funds holding Novavax